CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan First Wave BioPharma, Inc. - FWBI CFD

2.9699
0.98%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0802
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 0.001
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.9994
Open* 2.9691
1-Year Change* 172.39%
Day's Range* 2.87 - 2.9797
52 wk Range 2.76-289.80
Average Volume (10 days) 46.20K
Average Volume (3 months) 11.17M
Market Cap 4.70M
P/E Ratio -100.00K
Shares Outstanding 1.55M
Revenue N/A
EPS -248.68
Dividend (Yield %) N/A
Beta 1.69
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 27, 2023 2.9699 0.0004 0.01% 2.9695 3.0093 2.8700
Mar 24, 2023 2.9994 0.0199 0.67% 2.9795 3.0290 2.9692
Mar 23, 2023 3.0092 -0.0587 -1.91% 3.0679 3.1978 2.9791
Mar 22, 2023 3.0193 -0.0990 -3.17% 3.1183 3.1774 2.9687
Mar 21, 2023 3.1678 0.0892 2.90% 3.0786 3.1678 3.0582
Mar 20, 2023 3.0588 0.0499 1.66% 3.0089 3.1283 2.9691
Mar 17, 2023 3.0291 0.0600 2.02% 2.9691 3.0391 2.9591
Mar 16, 2023 2.9695 0.1986 7.17% 2.7709 3.0093 2.7704
Mar 15, 2023 2.9302 0.1883 6.87% 2.7419 2.9302 2.6917
Mar 14, 2023 2.7715 -0.1685 -5.73% 2.9400 2.9400 2.6912
Mar 13, 2023 3.0191 -0.5440 -15.27% 3.5631 3.5731 2.9982
Mar 10, 2023 3.6238 0.0103 0.29% 3.6135 3.6634 3.5640
Mar 9, 2023 3.7131 -0.2472 -6.24% 3.9603 4.1786 3.5639
Mar 8, 2023 3.5246 -0.0395 -1.11% 3.5641 3.6041 3.4648
Mar 7, 2023 3.5148 -0.0593 -1.66% 3.5741 3.7130 3.5047
Mar 6, 2023 3.6437 0.0800 2.24% 3.5637 3.7130 3.5637
Mar 3, 2023 3.6436 0.1790 5.17% 3.4646 3.7723 3.4646
Mar 2, 2023 3.5146 0.0496 1.43% 3.4650 3.5546 3.4650
Mar 1, 2023 3.5346 0.0200 0.57% 3.5146 3.5645 3.4650
Feb 28, 2023 3.4750 0.1891 5.75% 3.2859 3.5248 3.2856

First Wave BioPharma, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 0 0 0 0 0
Total Operating Expense 59.0569 26.8313 14.7437 13.4318 10.2212
Selling/General/Admin. Expenses, Total 18.3696 7.27976 6.04227 8.17431 6.93171
Research & Development 38.3204 19.105 7.85849 4.98555 2.39548
Depreciation / Amortization 0.015 0.048 0.84299 0.06191 0.754
Other Operating Expenses, Total 0 0.21 0.14
Operating Income -59.0569 -26.8313 -14.7437 -13.4318 -10.2212
Interest Income (Expense), Net Non-Operating -0.01007 -5.84013 -0.43394 -0.10185 -0.8752
Other, Net 0.5291 0
Net Income Before Taxes -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
Net Income After Taxes -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
Net Income Before Extra. Items -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
Net Income -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
Income Available to Common Excl. Extra. Items -84.5186 -41.7323 -15.1777 -13.5336 -11.0964
Income Available to Common Incl. Extra. Items -84.5186 -41.7323 -15.1777 -13.5336 -11.0964
Diluted Net Income -84.5186 -41.7323 -15.1777 -13.5336 -11.0964
Diluted Weighted Average Shares 0.0425 0.01354 0.01068 0.00735 0.00506
Diluted EPS Excluding Extraordinary Items -1988.67 -3082.15 -1421.4 -1840.94 -2192.55
Diluted Normalized EPS -1933.33 -3052.71 -1421.4 -1840.94 -2192.55
Revenue 0
Unusual Expense (Income) 2.35199 0.39857
Total Adjustments to Net Income -25.9807 -9.06087
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Total revenue 0 0 0 0 0
Total Operating Expense -4.38953 14.7879 9.38207 11.167 30.3995
Selling/General/Admin. Expenses, Total 2.90445 6.90451 4.40556 3.03678 6.02116
Research & Development 0.79107 7.88341 4.97652 5.77821 24.3783
Depreciation / Amortization
Operating Income 4.38953 -14.7879 -9.38207 -11.167 -30.3995
Interest Income (Expense), Net Non-Operating 0.0018 -0.00775 -0.00547 -0.00123 -0.00074
Other, Net 0 -0.2393 -0.2393 -0.00428 -0.00057
Net Income Before Taxes 4.39133 -15.035 -9.62684 -11.1725 -30.4008
Net Income After Taxes 4.39133 -15.035 -9.62684 -11.1725 -30.4008
Net Income Before Extra. Items 4.39133 -15.035 -9.62684 -11.1725 -30.4008
Net Income 4.39133 -15.035 -9.62684 -11.1725 -30.4008
Total Adjustments to Net Income -0.15758 -0.18792 -0.09079 -0.11623 -0.11809
Income Available to Common Excl. Extra. Items 4.23375 -15.2229 -9.71763 -11.2887 -30.5189
Income Available to Common Incl. Extra. Items 4.23375 -15.2229 -9.71763 -11.2887 -30.5189
Diluted Net Income 4.23375 -15.2229 -9.71763 -11.2887 -30.5189
Diluted Weighted Average Shares 0.23225 0.18244 0.09642 0.06153 9.34236
Diluted EPS Excluding Extraordinary Items 18.2291 -83.4388 -100.782 -183.468 -3.26672
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 18.2291 -83.4388 -100.782 -145.242 -3.26672
Unusual Expense (Income) 2.35199
Other Operating Expenses, Total -8.08505 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 9.42495 7.86978 3.40829 4.8 1.95257
Cash and Short Term Investments 8.24868 6.06214 0.1758 1.11434 0.57347
Cash 8.24868 6.06214 0.1758 1.11434 0.57347
Short Term Investments
Total Receivables, Net 0 0.55149 2.6373 3.17268 1.10413
Prepaid Expenses 1.17627 1.25615 0.59519 0.51298 0.27496
Total Assets 11.79 12.9239 8.90288 7.4694 5.47967
Property/Plant/Equipment, Total - Net 0.40931 0.09257 0.15978 0.12885 0.13399
Goodwill, Net 1.91171 2.05405 1.88669 1.92483 2.01624
Intangibles, Net 0 2.87954 3.40708 0.57048 1.34596
Other Long Term Assets, Total 0.04401 0.02792 0.04105 0.04523 0.03092
Total Current Liabilities 12.3004 15.5454 4.28564 2.99552 2.47908
Payable/Accrued 0 0.53343 0.6701 2.05534
Accrued Expenses 0.49706 0.18443 0.15441 0.53829 0.00719
Notes Payable/Short Term Debt 0.64124 0.55241 1.5213 0.25503 0.41655
Other Current Liabilities, Total 8.48018 13.25 0.39299
Total Liabilities 19.6115 15.5646 4.28564 2.99552 3.81908
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 7.31114 0.01912 0 0 1.34
Total Equity -7.82155 -2.64069 4.61724 4.47387 1.66059
Common Stock 0.00149 0.00312 0.00268 0.00177 0.00121
Additional Paid-In Capital 147.305 93.8349 68.5759 53.1393 37.6696
Retained Earnings (Accumulated Deficit) -153.904 -95.3662 -62.6947 -47.5171 -33.9834
Other Equity, Total -1.22414 -1.11255 -1.26656 -1.15011 -2.02679
Total Liabilities & Shareholders’ Equity 11.79 12.9239 8.90288 7.4694 5.47967
Total Common Shares Outstanding 14.8559 3.11503 2.68005 1.77049 1.20426
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Property/Plant/Equipment, Total - Gross 0.42402 0.13097 0.4233 0.33225
Accumulated Depreciation, Total -0.01471 -0.0384 -0.26352 -0.20339
Accounts Payable 2.68191 1.55859 1.68351 1.53211
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 6.55017 9.42495 7.50249 8.61528 13.1704
Cash and Short Term Investments 5.69499 8.24868 7.21065 8.07449 12.0256
Cash 5.69499 8.24868 7.21065 8.07449 12.0256
Total Receivables, Net 0.02806 0 0 0 0.50166
Prepaid Expenses 0.82713 1.17627 0.29184 0.54079 0.64313
Total Assets 8.82544 11.79 12.424 13.7768 17.9829
Property/Plant/Equipment, Total - Net 0.3788 0.40931 0.44889 0.48488 0.06162
Property/Plant/Equipment, Total - Gross 0.40083 0.42402 0.45632 0.4861 0.0812
Accumulated Depreciation, Total -0.02203 -0.01471 -0.00743 -0.00123 -0.01958
Goodwill, Net 1.86207 1.91171 1.94474 1.99129 1.97396
Intangibles, Net 0 2.48388 2.61576 2.74765
Other Long Term Assets, Total 0.0344 0.04401 0.04403 0.0696 0.02924
Total Current Liabilities 14.2157 12.3004 19.0983 6.45412 3.57464
Accounts Payable 3.44993 2.68191 18.4478 4.44991 1.44072
Accrued Expenses 0.7883 0.49706 0.22987 0.31246 0.32383
Notes Payable/Short Term Debt 0.40277 0.64124 0 0.13957 0.34708
Other Current Liabilities, Total 9.57473 8.48018 0.42063 1.55218 1.46302
Total Liabilities 18.0652 19.6115 19.394 6.73988 3.58121
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 3.8495 7.31114 0.29569 0.28575 0.00657
Total Equity -9.23979 -7.82155 -6.96999 7.03692 14.4017
Common Stock 0.00215 0.00149 0.00111 0.00826 0.00749
Additional Paid-In Capital 155.571 147.305 137.028 120.585 118.693
Retained Earnings (Accumulated Deficit) -163.531 -153.904 -142.732 -112.331 -103.052
Other Equity, Total -1.28254 -1.22414 -1.26711 -1.2255 -1.24734
Total Liabilities & Shareholders’ Equity 8.82544 11.79 12.424 13.7768 17.9829
Total Common Shares Outstanding 21.5488 14.8559 11.1152 8.25851 7.49269
Preferred Stock - Non Redeemable, Net 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
Cash From Operating Activities -32.2882 -11.2215 -14.0335 -10.8693 -7.18464
Cash From Operating Activities 0.01471 0.0378 0.0631 0.06191 0.04952
Amortization 0.52755 0.52755 0.95695 0.73654 0.70448
Non-Cash Items 8.60641 6.73365 1.82513 3.57765 3.42595
Changes in Working Capital 17.101 14.1509 -1.70099 -1.7118 -0.26821
Cash From Investing Activities -10.3195 0.08735 -0.0241 -0.30547 -0.03217
Capital Expenditures -0.06949 -0.00417 -0.0241 -0.30547 -0.03217
Cash From Financing Activities 44.7635 17.0461 13.145 11.7121 6.01322
Financing Cash Flow Items 0
Issuance (Retirement) of Stock, Net 44.6747 14.1861 9.53834 11.9028 5.00923
Issuance (Retirement) of Debt, Net 0.08883 2.86003 3.60664 -0.19068 1.00399
Foreign Exchange Effects 0.03076 -0.02559 -0.02593 0.00354 0.00353
Net Change in Cash 2.18654 5.88635 -0.93855 0.54087 -1.20005
Cash Taxes Paid 0 0 0 0
Cash Interest Paid 0 0.10546 0.00803 0.00401 0.00415
Other Investing Cash Flow Items, Total -10.25 0.09152
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -9.62684 -58.5378 -47.3654 -16.9646 -7.68563
Cash From Operating Activities -7.91207 -32.2882 -26.4254 -10.6961 -5.07339
Cash From Operating Activities 0.00732 0.01471 0.00939 0.00301 0.00102
Amortization 0 0.52755 0.39566 0.26377 0.13189
Non-Cash Items 0.36042 8.60641 2.04186 1.7359 1.80638
Cash Interest Paid 0 0 0 0 0.00514
Changes in Working Capital 1.34703 17.101 18.493 4.26576 0.67294
Cash From Investing Activities -10.3195 -10.3215 -9.07393 0
Capital Expenditures -0.06949 -0.07145 -0.07393 0
Cash From Financing Activities 5.36715 44.7635 37.9406 21.8326 11.0506
Financing Cash Flow Items -2.41496 -9.53235
Issuance (Retirement) of Stock, Net 8.02057 44.6747 38.493 22.2454 20.7883
Issuance (Retirement) of Debt, Net -0.23847 0.08883 -0.55241 -0.41284 -0.20532
Foreign Exchange Effects -0.00877 0.03076 -0.04525 -0.05019 -0.01374
Net Change in Cash -2.5537 2.18654 1.1485 2.01235 5.96349
Cash Taxes Paid 0 0 0
Other Investing Cash Flow Items, Total -10.25 -10.25 -9
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Armistice Capital LLC Hedge Fund 2.7101 41995 41995 2022-12-31 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.7614 11799 0 2022-12-31 LOW
Sapirstein (James E) Individual Investor 0.6914 10714 -32143 2023-03-16 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.4632 7178 7178 2022-12-31 MED
Romano (Sarah M.) Individual Investor 0.3457 5357 -16072 2023-03-16 MED
Hoffman (David Andrew) Individual Investor 0.2509 3888 -9080 2023-03-16 HIGH
Borkowski (Edward J) Individual Investor 0.2083 3228 -9080 2023-03-16 LOW
Riddell (Alastair) Individual Investor 0.1993 3089 -9080 2023-03-16 HIGH
Casamento (Charles J) Individual Investor 0.1989 3082 -9080 2023-03-16 LOW
Coelho (Mary Theresa) Individual Investor 0.1953 3027 -9079 2023-03-16 LOW
Susquehanna International Group, LLP Investment Advisor 0.1408 2182 2182 2022-12-31 MED
UBS Financial Services, Inc. Investment Advisor 0.1315 2038 1752 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.0987 1529 1529 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.063 977 0 2023-02-28 LOW
Tower Research Capital LLC Hedge Fund 0.0626 970 497 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.0243 377 0 2022-12-31 LOW
Advisor Group, Inc Investment Advisor 0.0185 286 286 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.0017 27 0 2022-12-31 LOW
U.S. Bancorp Asset Management, Inc. Investment Advisor 0.0015 24 0 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.0014 22 0 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Biotechnology & Medical Research (NEC)

777 Yamato Road
Suite 502
BOCA RATON
FLORIDA 33431
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,698.60 Price
+0.050% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

XRP/USD

0.49 Price
+2.780% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00418

Oil - Crude

72.86 Price
-0.050% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short -0.0039%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

BTC/USD

27,103.30 Price
+0.100% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda